Literature DB >> 16388877

Interactions between the melanocortin system and the hypothalamo-pituitary-thyroid axis.

Niamh M Martin1, Kirsty L Smith, Stephen R Bloom, Caroline J Small.   

Abstract

Recent studies of transgenic mice and humans have provided compelling evidence for the importance of the hypothalamic melanocortin system in the regulation of energy balance. Energy homeostasis is a balance between food intake (energy input) and energy expenditure. The melanocortin system regulates feeding via effects of the endogenous agonist, alpha-melanocyte stimulating hormone (alpha-MSH) and the endogenous antagonist agouti-related protein (AGRP) on melanocortin 3 and 4 receptors (MC3-Rs and MC4-Rs). It has been demonstrated that the melanocortin system interacts with the hypothalamo-pituitary-thyroid (HPT) axis. Thyroid hormones influence metabolism and hence energy expenditure. Therefore, an interaction between the HPT axis and the melanocortin system would allow control of both sides of the energy balance equation, by the regulation of both energy input and energy expenditure. Here we will discuss the evidence demonstrating interactions between the melanocortin system and the HPT axis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388877     DOI: 10.1016/j.peptides.2005.01.028

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Neonatal overfeeding leads to developmental programming of adult obesity: you are what you ate.

Authors:  L J Prior; J A Armitage
Journal:  J Physiol       Date:  2009-06-01       Impact factor: 5.182

2.  The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia.

Authors:  R Dallmann; P Weyermann; C Anklin; M Boroff; K Bray-French; B Cardel; I Courdier-Fruh; H Deppe; J Dubach-Powell; M Erb; R H Haefeli; M Henneböhle; H Herzner; M Hufschmid; D L Marks; S Nordhoff; M Papp; C Rummey; G Santos; F Schärer; H Siendt; M Soeberdt; L T Sumanovski; M Terinek; C Mondadori; N Güven; A Feurer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-08-28       Impact factor: 12.910

3.  Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients.

Authors:  Seray Külcü Çakmak; Nimet Özcan; Arzu Kılıç; Suha Koparal; Ferda Artüz; Atıl Çakmak; Kenan Köse
Journal:  Postepy Dermatol Alergol       Date:  2015-10-29       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.